4
Changes in Ownership
TherapeuticsMD, Inc. Filed Acc 0001209191-22-060586
Co-Chief Executive Officer sold 440 shares at $4.92 ($2,165)
- Co-Chief Executive Officer acquired 1,734 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Glickman Mark A · Co-Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-12-06 | Exercise or conversion : show line 1 in the form | +1,734 | 1,734 | D | ||
| 2022-12-06 | Sale : show line 2 in the form | −440 | $4.92 | $2,165 | 1,294 | D |
| Open-market sales · 440 sh · avg $4.92 · $2,165 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-12-06 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −1,734 | 3,466 | D |
Loading xslF345X03/doc4.xml…